Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.530
-0.080 (-3.07%)
Nov 21, 2024, 4:00 PM EST - Market closed
Vistagen Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 68 | 143 | 27 | 256 | 305 | 22 | |
| Market Cap Growth | 66.08% | 421.73% | -89.32% | -16.12% | 1309.99% | -60.31% | |
| Enterprise Value | -27 | 18 | 5 | 176 | 211 | 29 | |
| Last Close Price | 2.53 | 5.28 | 3.74 | 37.20 | 63.90 | 13.20 | |
| PS Ratio | 87.53 | 134.11 | -120.48 | 230.94 | 280.23 | - | |
| PB Ratio | 0.74 | 1.25 | 2.26 | 3.96 | 3.11 | -30.18 | |
| P/TBV Ratio | 0.88 | 1.25 | 2.26 | 3.96 | 3.32 | - | |
| EV/Sales Ratio | - | 17.28 | - | 158.30 | 193.50 | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.22 | 0.05 | 0.04 | -5.70 | |
| Asset Turnover | 0.01 | 0.01 | - | 0.01 | 0.02 | - | |
| Quick Ratio | 12.97 | 23.26 | 3.64 | 11.88 | 24.62 | 0.49 | |
| Current Ratio | 13.29 | 23.55 | 3.83 | 12.32 | 24.85 | 0.57 | |
| Return on Equity (ROE) | -61.52% | -46.47% | -154.30% | -58.62% | -36.78% | -411.13% | |
| Return on Assets (ROA) | -39.39% | -28.52% | -77.39% | -32.65% | -19.66% | -131.43% | |
| Return on Capital (ROIC) | -42.92% | -31.46% | -89.75% | -35.19% | -21.28% | -182.29% | |
| Earnings Yield | -57.80% | -20.58% | -216.63% | -18.65% | -5.87% | -95.94% | |
| FCF Yield | -49.16% | -18.13% | -182.55% | -17.75% | -4.04% | -72.77% | |
| Buyback Yield / Dilution | -284.96% | -178.13% | -5.45% | -129.85% | -96.34% | -53.59% | |
| Total Shareholder Return | -284.96% | -178.13% | -5.45% | -129.85% | -96.34% | -53.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.